Pharmacokinetics and Bioequivalence Study of Two Proton Pump Inhibitor Products

Journal Title: Journal of Pharmaceutical Research International - Year 2016, Vol 13, Issue 6

Abstract

Omeprazole (OPZ) efficiently suppresses acid secretion in the parietal cells of the stomach. It is widely recommended as proton pump inhibitor (PPI) in Egypt. Presence of many products containing omeprazole available in the Egyptian market raises questions of generic substitution and/or therapeutic equivalence. The aim of the study was to compare the pharmacokinetic parameters and relative bioequivalence properties of two oral omeprazole formulations, GastrolocĀ® and PepzolĀ® enteric coated capsules, in healthy subjects. A randomized, two-way crossover study was conducted to study the pharmacokinetic parameters of the OPZ products in 24 healthy human volunteers in compliance with the Declaration of Helsinki and ICH guidelines. After oral administration and at specified time intervals, blood samples were collected and analyzed for plasma OPZ content using a validated HPLC method. The Pharmacokinetic parameters such as AUC0-12, Cmax, Tmax, t1/2 and elimination rate constant were determined from plasma concentration-time profile for both formulations by a non-compartmental method. The statistical analysis of the data obtained in this study showed no significant difference between the tested OPZ products. The results indicated that the tested products have similar bioavailability profiles and therefore can be considered bioequivalent based on the obtained data of AUC, Cmax, and Tmax.

Authors and Affiliations

Ehab Ibrahim Taha, Fathy Ibrahim Abd-Alla

Keywords

Related Articles

Antifungal, Antioxidant and Phytochemical Screening of Melia azedarach Flower Extracts by Using Different Solvents

Objective: To investigate the antifungal, antioxidant and phytochemical screening of Melia azedarach flowers by using different solvents. Materials and Methods: Antifungal activity was experimented against three fungi (A...

Cytotoxicity of Enterolobium timbouva Plant Extract and Its Isolated Pure Compounds

Aims: The present study aimed to evaluate the cytotoxic activities of the aqueous alcohol extract of Enterolobium timbouva leaves as well as its isolated pure compounds. Place and Duration of Study: Department of Pharma...

Hepatoprotective Activity of Leaf and Leaf Callus Extracts of Orthosiphon aristatus (Blume) Miq.

Aim: The study was carried out to evaluate the in vitro hepatoprotective activity of leaf and leaf callus extracts of Orthosiphon aristatus against alcohol induced toxicity using HepG2 cell line. Materials and Methods: L...

A Novel Acyl-CoA: Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitor, GSK2973980A, Inhibits Postprandial Triglycerides and Reduces Body Weight in a Rodent Diet-induced Obesity Model

Background and Aim: Acyl-CoA: diacylglycerol acyltransferase 1 (DGAT1) is a key enzyme catalyzing the final step of triglyceride (TG) synthesis and is implicated in fat absorption and disposition. However, development of...

QSAR Pharmacophore-based Virtual Screening, CoMFA and CoMSIA Modeling and Molecular Docking towards Identifying Lead Compounds for Breast Cancer Protease Inhibitors

Aim: This study used QSAR Pharmacophore-based virtual screening and molecular docking to identify lead compounds and determine structural requirements for breast cancer inhibitor development. CoMFA and CoMSIA modeling wa...

Download PDF file
  • EP ID EP342518
  • DOI 10.9734/BJPR/2016/29952
  • Views 106
  • Downloads 0

How To Cite

Ehab Ibrahim Taha, Fathy Ibrahim Abd-Alla (2016). Pharmacokinetics and Bioequivalence Study of Two Proton Pump Inhibitor Products. Journal of Pharmaceutical Research International, 13(6), 1-8. https://www.europub.co.uk/articles/-A-342518